Alpha Tau Medical

DRTS Lead: Phase 2 16 Biotech Distilled articles ↓

Most recent annual filing: 2025-12-31

Catalyst timeline

GBM Brain corporate update2026GBM Brain corporate update, 2026, routine
Head & Neck Cancer +2026Head & Neck Cancer +, 2026, routine
Alpha DaRT SCC pivotal topline3Q 2026Alpha DaRT SCC pivotal topline, 3Q 2026, thesis-defining
IMPACT pancreas pilot corporate updateLate 2026 / early 2027IMPACT pancreas pilot corporate update, Late 2026 / early 2027, routine

Bar width shows how precise the guidance is — a pin is a stated date, a wide band a six-month window. Deeper blue means more of the thesis rides on the event; it is not a view on the stock.

Pipeline (5 active programs)

Alpha DaRT

Radioligand

Cutaneous Squamous Cell Carcinoma Phase 2 intratumoral
Skin Cancer Phase 2 intratumoral
Pancreatic Cancer Phase 2 intratumoral
Head and Neck Squamous Cell Carcinoma Phase 2 intratumoral
Glioblastoma Multiforme Phase 1 intratumoral

Biotech Distilled coverage (16)

2026-08-11 UPDATE: Alpha Tau Medical (DRTS) — The Share Count Answer, And a $68.8M Loss That Isn’t 🔒 Paid
2026-07-21 UPDATE: Alpha Tau Medical (DRTS) — The Abscopal Bet Cashes a Ticket 🔒 Paid
2026-06-12 UPDATE: Alpha Tau Medical (DRTS) — FDA Greenlights REGAIN Expansion, Two New Sites Join
2026-06-03 UPDATE: Alpha Tau Medical (DRTS) — Tolmar Takes Prostate, And It Pays a Premium
2026-06-01 UPDATE: Alpha Tau Medical (DRTS) — The Pancreas OS Number Lands, And It’s Better Than the Benchmarks 🔒 Paid
2026-05-12 UPDATE: Alpha Tau Medical (DRTS) — The Unforgiving Organ Talks Back, And It Says Yes 🔒 Paid
2026-05-08 UPDATE: Alpha Tau Medical (DRTS) — ReSTART Enrollment Done, GBM Safety Call Set, Italy Opens 🔒 Paid
2026-05-04 UPDATE: Alpha Tau Medical (DRTS) — 100% Local Disease Control at the DDW Podium
2026-04-29 UPDATE: Alpha Tau Medical (DRTS) — The $300M Shelf Lands, ASCO Caps the Pancreas Run 🔒 Paid
2026-04-27 UPDATE: Alpha Tau Medical (DRTS) — The Pancreas Franchise Goes Global, IMPACT Slips a Quarter 🔒 Paid
2026-03-14 UPDATE: Alpha Tau (DRTS) - FY25 Financials 🔒 Paid
2026-02-28 UPDATE: Alpha Tau (DRTS) – The Japan Catalyst Hits 🔒 Paid
2026-01-30 UPDATE: Alpha Tau (DRTS) Doubles Down on the U.S. 🔒 Paid
2026-01-07 UPDATE: Alpha Tau Medical (DRTS) – Pancreatic Data Hits the "Safety" Bullseye; FDA Submission Adds Regulatory Momentum 🔒 Paid
2026-01-04 The Alpha Wars: Physics vs. Chemistry (DRTS vs. CATX) 🔒 Paid
2026-01-03 Alpha Tau Medical (DRTS): Scientific Deep Dive of Alpha DaRT 🔒 Paid

Articles open on Substack. Some deep dives are subscriber-only.